-
My Account
Think Deals,
Think Moneycontrol
Stay ahead of the market with comprehensive M&A insights, deal analysis, and strategic intelligence for informed business decisions.
Stay ahead with sharp M&A analysis and strategic market intelligence
Think Deals, Think Moneycontrol
Mergers and Acquisitions
Acquisitions
Prosus picks up 10% stake at Rs 1,295 crore in Ixigo’s parent, funds to fuel AI, hotel expansion
The company will use the sume, Rs 1,295 crore, to fund AI investments and its hotel vertical among others
Acquisitions
Ashish Kacholia, Bengal Finance acquire 1.9% stake in TechEra Engineering
Acquisitions
CCI clears Lloyds Metals' proposal to acquire 49.9 pc stake in Thriveni Pellets
Acquisitions
Waaree Energies acquires 64% stake in Kotsons for Rs 192 crore
Acquisitions
Delhivery completes Rs 1,407 crore Ecom Express acquisition, kicks off six-month integration plan
Private Equity
Business
Temasek enters exclusive talks for minority stake in Romsons Group at around $1bn valuation
The proposed transaction would provide growth capital to Romsons Group for approaching new markets and aid in potential inorganic activity
Business
Investcorp's new Rs 5,000 crore PE fund to target mid-market buyouts, says India head Gaurav Sharma
The fund, backed by both domestic and global investors, will target building a portfolio of 10–11 companies across healthcare, business services, consumer, and financial sectors, Investcorp India investment business head Gaurav Sharma tells Moneycontrol
Business
Private equity fund True North exploring sale of controlling stake in pharma firm Integrace
Early discussions have kickstarted with a few select suitors keen on a domestic formulations platform. Temasek is the other key shareholder in Integrace.
IPOs
Business
Emmvee Photovoltaic IPO to open for public on November 11, anchor investors pick Rs 1,305-crore shares
Emmvee Photovoltaic IPO | The company aims to mop up Rs 2,900 crore via IPO which is a mix of fresh issuance of shares worth Rs 2,143.9 crore, and an offer-for-sale of Rs 756.1 crore worth shares by promoters.
Business
PhysicsWallah raises Rs 1,563 crore via anchor book, Rs 3,480-crore IPO to open on November 11
Business
Manipal Payment and Identity Solutions files Updated DRHP with SEBI for IPO
Business
SEBI clears IPO papers of Nephrocare Health Services, Clean Max Enviro Energy Solutions
Business
PhysicsWallah IPO opens tomorrow, GMP declines: Here's why brokerages are 'Neutral' on the Rs 3,480-crore IPO
Venture Capital
Business
Carlyle Group-backed Katsura Investments transfers 1.21% stake to promoter, valuing IPO-bound Varmora Granito at Rs 4,500 crore
Varmora Granito IPO | The company will issue fresh shares worth Rs 400 crore, while Katsura Investments and promoters will be offloading 5.24 crore shares via offer-for-sale route.
Business
TAM doesn’t matter. I don’t track it, that is an analyst’s job, says Lenskart’s Peyush Bansal
Even if it is Rs 5,000 crore, we can give vision to 50 percent of India and that is a sizable impact to create and so our job is not changing because of that, Peyush Bansal, CEO and co-founder, Lenskart, told Moneycontrol in an interview.
Business
Accel and Prosus to co-invest in former’s early-stage founder programme Atoms X
Prosus will match Accel’s investment in each company. Earlier each company would get around $250,000 to $1 million in funding but now they’ll be able to raise around $500,000 to $2 million at the early stage.
IPO (Initial Public Offerings)
Pine Labs
IPO opens for subscription on 2025-11-07 and closes on 2025-11-11. Pine Labs IPO price band is set at 210.00 to 221.00 per share.
| Details | |
|---|---|
| Open Date | Nov 7, 2025 |
| Close Date | Nov 11, 2025 |
| Issue Price | ₹210 - ₹221 |
| Lot Size | 67 |
| Issue Size | ₹3899.91 Cr |
Subscription and IPO dates
| Subscription | |
|---|---|
| Category | Subscription Times |
| Qualified Institutional Buyers | 0.64x |
| Retail Individual Investor | 0.87x |
| Non-Institutional Investor | 0.12x |
| Others | 4.9x |
| Total | 0.54x |
| IPO Dates | |
|---|---|
| 2025-11-12 | Basis of Allotment |
| 2025-11-13 | Initiation of Refunds |
| 2025-11-13 | Credit of Shares |
| 2025-11-14 | Listing Date |
| Subscription | |
|---|---|
| Category | Subscription Times |
| Qualified Institutional Buyers | 0.64x |
| Retail Individual Investor | 0.87x |
| Non-Institutional Investor | 0.12x |
| Others | 4.9x |
| Total | 0.54x |
| IPO Dates | |
|---|---|
| 2025-11-12 | Basis of Allotment |
| 2025-11-13 | Initiation of Refunds |
| 2025-11-13 | Credit of Shares |
| 2025-11-14 | Listing Date |
Emmvee Photovoltaic Power
IPO opens for subscription on 2025-11-11 and closes on 2025-11-13. Emmvee Photovoltaic Power IPO price band is set at 206.00 to 217.00 per share.
| Details | |
|---|---|
| Open Date | Nov 11, 2025 |
| Close Date | Nov 13, 2025 |
| Issue Price | ₹206 - ₹217 |
| Lot Size | 69 |
| Issue Size | ₹2900.00 Cr |
Subscription and IPO dates
| Subscription | |
|---|---|
| Category | Subscription Times |
| Qualified Institutional Buyers | - |
| Retail Individual Investor | - |
| Non-Institutional Investor | - |
| Others | - |
| Total | - |
| IPO Dates | |
|---|---|
| 2025-11-14 | Basis of Allotment |
| 2025-11-17 | Initiation of Refunds |
| 2025-11-17 | Credit of Shares |
| 2025-11-18 | Listing Date |
| Subscription | |
|---|---|
| Category | Subscription Times |
| Qualified Institutional Buyers | - |
| Retail Individual Investor | - |
| Non-Institutional Investor | - |
| Others | - |
| Total | - |
| IPO Dates | |
|---|---|
| 2025-11-14 | Basis of Allotment |
| 2025-11-17 | Initiation of Refunds |
| 2025-11-17 | Credit of Shares |
| 2025-11-18 | Listing Date |
Bulk Deals
Nov 10, 2025
SPRIGHT
Sold byPlantflow trade private limited- Quantity13131679
- Traded Price0.67
- Deal Value (Rs. Cr.)0.87
- % Traded1.23
- exchangeBSE
Nov 10, 2025
Welcure Drugs
Bought byShare india securities limited- Quantity7906387
- Traded Price0.57
- Deal Value (Rs. Cr.)0.45
- % Traded0.64
- exchangeBSE
Nov 10, 2025
Welcure Drugs
Sold byModupalli ramesh- Quantity7000000
- Traded Price0.56
- Deal Value (Rs. Cr.)0.39
- % Traded0.56
- exchangeBSE
Nov 10, 2025
Welcure Drugs
Sold byShare india securities limited- Quantity5459600
- Traded Price0.56
- Deal Value (Rs. Cr.)0.30
- % Traded0.43
- exchangeBSE
Block Deals
Nov 10, 2025
ICICI Bank
Sold byGoldman sachs bank europese-odi- Quantity141886
- Traded Price1332
- Deal Value (Rs. Cr.)18.89
- % Traded0.00
- exchangeNSE
Nov 10, 2025
ICICI Bank
Bought byBofa securities europe sa- Quantity141886
- Traded Price1332
- Deal Value (Rs. Cr.)18.89
- % Traded0.00
- exchangeNSE
Nov 10, 2025
Apollo Hospital
Bought byBofa securities europe sa- Quantity92363
- Traded Price7474
- Deal Value (Rs. Cr.)69.03
- % Traded0.06
- exchangeNSE
Nov 10, 2025
Apollo Hospital
Sold byGoldman sachs bank europese-odi- Quantity92363
- Traded Price7474
- Deal Value (Rs. Cr.)69.03
- % Traded0.06
- exchangeNSE
VC Deals of the Week
powered by:
Moneycontrol’s M&A Team
Ashwin Mohan
Senior Editor- M&A
N Mahalakshmi
Senior Consulting Editor
Swaraj Singh Dhanjal
Assistant Editor
Pavan Burugula
Assistant Editor
Trending Topics
Latest News
The Deal Factor
Step into the exciting and high-adrenaline world of deals with our editorial page dedicated to the latest strategic and value-unlocking moves in India Inc and the capital markets. This special page offers exclusive scoops and unmatched analysis on mergers and acquisitions, private equity and equity capital market transactions including IPO's, block trades and QIPs.
From mega buyouts which move the markets to public issues which thrill investors to interviews with global dealmakers and top CEO's to regulatory and policy shakeup's which impact the playbook of stakeholders, our crack team of seasoned journalists and sector specialists will work round the clock to ensure you catch it here first!
That’s not all! We will also offer you the best- in-class data with features like weekly deal trackers, IPO pipeline and status checks and more. Not to mention, highlight the key trends across segments and investor classes which are shaping the domestic business environment amid a period of global geo-political uncertainty and market volatility.
Whether you are a corporate executive, market analyst, investor, lawyer, banker, tax expert or even a curious student, this page is your essential daily guide to stay ahead of the curve and arrive at informed decisions based on our reliable, razor-sharp and timely news, perspective and intelligence.